Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Abeona Therapeutics Inc
ABEOCurrent price
4.66 USD
-0.14 USD (-2.92%)
Last closed
4.8 USD
Company
www.abeonatherapeutics.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
122 132 368 USD
Yield for 12 month
+23.94 %
Week
Month
Year
ABEO
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York. Address: 1330 Avenue of the Americas, New York, NY, United States, 10019
Analytics
WallStreet Target Price
21.25 USDP/E ratio
–Dividend Yield
3.82 %Current Year
+1 414 000 USD
Last Year
+3 000 000 USD
Current Quarter
–
Last Quarter
+3 500 000 USD
Current Year
+964 000 USD
Last Year
+3 000 000 USD
Current Quarter
-30 000 USD
Last Quarter
+1 925 000 USD
Key Figures ABEO
1 year
3 years
5 years
10 years
EBITDA
-44 451 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-56.01 %
PEG Ratio
–
Return On Equity TTM
-238.81 %
Wall Street Target Price
21.25 USD
Revenue TTM
3 568 000 USD
Book Value
0.89 USD
Revenue Per Share TTM
0.2 USD
Dividend Share
–
Quarterly Revenue Growth YOY
250 %
Dividend Yield
3.82 %
Gross Profit TTM
-28 001 000 USD
Earnings Share
-1.37 USD
Diluted Eps TTM
-1.37 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ABEO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABEO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
3.82 %
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
05.07.2022
Dividend Date
–
Stock Valuation ABEO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
20.5514
Price Sales TTM
34.2299
Enterprise Value EBITDA
-1.7997
Price Book MRQ
5.5082
Financials ABEO
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators ABEO
For 52 weeks
2.19 USD
5.4 USD
50 Day MA
4.15 USD
Shares Short Prior Month
630 363
200 Day MA
3.58 USD
Short Ratio
7.4
Shares Short
603 694
Short Percent
2.69 %
Google
Apple
Facebook